Pharma Firms Ready To Repatriate Billions Once “JOBS” Bill Is Signed
This article was originally published in The Tan Sheet
Executive Summary
J&J intends to repatriate as much as $10 bil. held by foreign subsidiaries following President Bush's expected signing of the "JOBS" bill
You may also be interested in...
Repatriated Funds Should Not Be Used For Liability Costs – Congressman
The U.S. Treasury Department should clarify that pharmaceutical companies cannot use the tax repatriation provision of a recently enacted jobs bill to cover tort and liability expenses, House Ways & Means Health Subcommittee Ranking Member Pete Stark (D-Calif.) maintains
Repatriated Funds Should Not Be Used For Liability Costs – Congressman
The U.S. Treasury Department should clarify that pharmaceutical companies cannot use the tax repatriation provision of a recently enacted jobs bill to cover tort and liability expenses, House Ways & Means Health Subcommittee Ranking Member Pete Stark (D-Calif.) maintains
Repatriated Funds Should Not Be Used For Liability Costs – Congressman
The U.S. Treasury Department should clarify that pharmaceutical companies cannot use the tax repatriation provision of a recently enacted jobs bill to cover tort and liability expenses, House Ways & Means Health Subcommittee Ranking Member Pete Stark (D-Calif.) maintains